DRKS00019872
Completed
Not Applicable
Establishing age-dependent cut-offs for pathological brain volume loss in the thalamus. - AgeDepThal
Celgene GmbH0 sites1,100 target enrollmentNovember 22, 2019
ConditionsG35.1
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- G35.1
- Sponsor
- Celgene GmbH
- Enrollment
- 1100
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •andere Erkrankungen
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
REDucing Unneeded EndoScopiesNL-OMON25468Jeroen Bosch Hospital stipendium1,500
Completed
Not Applicable
The age-related changes of the meibomian glands in healthy participantsMeibomian gland dysfunctionDry eyeEye - Normal eye development and functionACTRN12612000703808Brien Holden Vision Institute200
Completed
Not Applicable
A new approach to determine the age of (sub)acute and chronic subdural hematomasNL-OMON50105Academisch Medisch Centrum25
Active, not recruiting
Phase 1
Ang-1 study by various age groupsHealthy personsProblem studied: Vasculopathy in Systemic Sclerosis.AngiopoietinJPRN-jRCT1050230011Shima Yoshihito60
Completed
Not Applicable
Age as a Limit SituatioF32F33Depressive episodeRecurrent depressive disorderDRKS00023139niversitätsklinik für Psychiatrie und Psychotherapie an der Karl-Jaspers-Klinik, Medizinischer Campus der Universität Oldenburg13